Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1910

1.

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y.

Arch Gen Psychiatry. 2006 Apr;63(4):426-32.

PMID:
16585472
2.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289
3.

Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.

Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR.

Aust N Z J Psychiatry. 2007 Nov;41(11):896-902.

PMID:
17924242
4.

Group intervention for coexisting psychosis and substance use disorders in rural Australia: outcomes over 3 years.

Bradley AC, Baker A, Lewin TJ.

Aust N Z J Psychiatry. 2007 Jun;41(6):501-8.

PMID:
17508320
5.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
6.

[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.

Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19. French.

PMID:
19540408
7.

A national study of violent behavior in persons with schizophrenia.

Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA, Stroup TS, McEvoy JP, Lieberman JA.

Arch Gen Psychiatry. 2006 May;63(5):490-9.

PMID:
16651506
8.

Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL; Cost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):449-58. doi: 10.1097/QAI.0b013e3181642244.

PMID:
18197121
9.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
10.

The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.

McKay JR, Lynch KG, Shepard DS, Pettinati HM.

Arch Gen Psychiatry. 2005 Feb;62(2):199-207.

PMID:
15699297
11.

Long-term effectiveness and cost of a systematic care program for bipolar disorder.

Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B.

Arch Gen Psychiatry. 2006 May;63(5):500-8.

PMID:
16651507
12.

The prevalence of mental and physical health disorders among older methadone patients.

Rosen D, Smith ML, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2008 Jun;16(6):488-97. doi: 10.1097/JGP.0b013e31816ff35a.

PMID:
18515693
13.

The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.

Tsuang D, Cowley D, Ries R, Dunner DL, Roy-Byrne PP.

J Clin Psychiatry. 1995 Dec;56(12):549-55.

PMID:
8530330
14.

Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.

J Ment Health Policy Econ. 2009 Mar;12(1):33-46.

PMID:
19346565
15.

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.

Arch Gen Psychiatry. 2005 Oct;62(10):1148-56.

PMID:
16203960
16.

The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Elbogen EB, Johnson SC.

Arch Gen Psychiatry. 2009 Feb;66(2):152-61. doi: 10.1001/archgenpsychiatry.2008.537.

PMID:
19188537
17.

Approach to treatment of mental illness and substance dependence in remote Indigenous communities: results of a mixed methods study.

Nagel T, Robinson G, Condon J, Trauer T.

Aust J Rural Health. 2009 Aug;17(4):174-82. doi: 10.1111/j.1440-1584.2009.01060.x.

PMID:
19664081
18.

Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder.

McCormick B, Blum N, Hansel R, Franklin JA, St John D, Pfohl B, Allen J, Black DW.

Compr Psychiatry. 2007 Sep-Oct;48(5):406-12. Epub 2007 Jul 5.

PMID:
17707247
19.

Behavioral treatment of substance abuse in schizophrenia.

Tenhula WN, Bennett ME, Strong Kinnaman JE.

J Clin Psychol. 2009 Aug;65(8):831-41. doi: 10.1002/jclp.20613.

PMID:
19551711
20.

Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.

Sokolski KN, Cummings JL, Abrams BI, DeMet EM, Katz LS, Costa JF.

J Clin Psychiatry. 1994 Sep;55(9):380-7.

PMID:
7929017

Supplemental Content

Support Center